SEARCH VEGSOURCE:

 

 

Follow Ups | Post Followup | Back to Discussion Board | VegSource
See spam or
inappropriate posts?
Please let us know.
  




From: TSS ()
Subject: Haemophilia: Creutzfeldt-Jakob Disease
Date: May 26, 2005 at 8:28 pm PST

##################### Bovine Spongiform Encephalopathy #####################

Haemophilia: Creutzfeldt-Jakob Disease
Lord Morris of Manchester asked Her Majesty's Government:

What is their latest information on the number of patients with haemophilia whose National Health Service treatment could have involved the use of blood from donors now known to have had variant Creutzfeldt-Jakob disease. [HL30]

Lord Warner: The United Kingdom Haemophilia Centre Doctors' Organisation is currently collecting information on the number of haemophilia patients considered to be at risk. When this exercise has been completed we will be in a position to provide an estimate on the number of haemophilia patients who have been exposed to plasma products which may be implicated with variant Creutzfeldt-Jakob disease.

http://www.publications.parliament.uk/pa/ld199697/ldhansrd/pdvn/lds05/text/50525w01.htm#50525w01_sbhd4

Haemophilia: Recombinant Treatment
Lord Morris of Manchester asked Her Majesty's Government:

When they expect recombinant treatment to be available for haemophilia patients throughout England; and to how many such patients it is currently unavailable. [HL29]

The Minister of State, Department of Health (Lord Warner): This is the third and final year of the recombinant roll-out programme. All haemophilia patients in England are eligible for treatment with recombinant products in this financial year. Data on the roll-out are collected by the United Kingdom Haemophilia Centre Doctors' Organisation. However, figures are not yet available on the first quarter of this financial year.

http://www.publications.parliament.uk/pa/ld199697/ldhansrd/pdvn/lds05/text/50525w01.htm#50525w01_sbhd4

TSS

#################### https://lists.aegee.org/bse-l.html ####################




Follow Ups:



Post a Followup

Name:
E-mail: (optional)
Subject:

Comments:

Optional Link URL:
Link Title:
Optional Image URL: